Literature DB >> 3448501

[A case of prolactinoma associated with craniopharyngioma].

J Asari1, K Yamanobe, T Sasaki, N Yamao, N Kodama.   

Abstract

A surgical case of prolactinoma associated with craniopharyngioma is reported. A 47-year-old man was admitted to some neurosurgical clinic on October 12, 1982, because of visual disturbance, general fatigue and impotence. Laboratory study revealed hyperprolactinemia (360 ng/ml) and slight enlargement of sella turcica indicated the pituitary adenoma. Transsphenoidal surgery was performed to remove the tumor on November 20, 1982. Histopathological examination revealed chromophobe adenoma, and prolactin was stained in the tumor cells by means of immunoperoxidase staining. Though the clinical symptoms had been improved after surgery, visual disturbance became worse about one month later. At that time empty sella syndrome was suspected and the second operation (interhemispheric approach) was performed on January 21, 1983. No pathological changes were observed at all. On July 13, 1983, he was transferred to our clinic, because his visual acuity was deteriorating. At this time we reviewed the previous CT scan and noticed a suprasellar mass. It was supposed that the lesion had been overlooked and was the cause of the visual disturbance. On August 1, 1983, a bifrontal craniotomy was performed and the suprasellar tumor was removed. Pathological examination of the tumor revealed craniopharyngioma. So it was supposed that pituitary adenoma and craniopharyngioma had been coexisting since onset. Except for cases with von Recklinghausen's disease, multiple primary intracranial tumors of different cell types are relatively rare. A review of literature revealed 94 cases until 1986. The most frequent combination of multiple tumors was meningioma and glioma. But we could not find any case of pituitary adenoma associated with craniopharyngioma in the literature.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3448501

Source DB:  PubMed          Journal:  No Shinkei Geka        ISSN: 0301-2603


  7 in total

Review 1.  Collision lesions of the sella: co-existence of craniopharyngioma with gonadotroph adenoma and of Rathke's cleft cyst with corticotroph adenoma.

Authors:  N Karavitaki; B W Scheithauer; J Watt; O Ansorge; M Moschopoulos; A V Llaguno; J A H Wass
Journal:  Pituitary       Date:  2008       Impact factor: 4.107

Review 2.  Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.

Authors:  Stefano La Rosa; Fausto Sessa; Silvia Uccella
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

3.  Collision tumors of the sella: craniopharyngioma and silent pituitary adenoma subtype 3: case report.

Authors:  Olga Moshkin; Bernd W Scheithauer; Luis V Syro; Alejandro Velasquez; Eva Horvath; Kalman Kovacs
Journal:  Endocr Pathol       Date:  2009       Impact factor: 3.943

Review 4.  Association of craniopharyngioma and pituitary adenoma.

Authors:  Federica Guaraldi; Nunzia Prencipe; Valentina di Giacomo; Massimo Scanarini; Valentina Gasco; Marina Paola Gardiman; Alessandro M Berton; Ezio Ghigo; Silvia Grottoli
Journal:  Endocrine       Date:  2013-02-02       Impact factor: 3.633

5.  Ten-Year Follow-Up of Collision Tumors Composed of Craniopharyngioma and Pituitary Adenoma: A Case Report and Literature Review.

Authors:  Takeshi Miyazaki; Kentaro Kowari; Hirotake Eda; Mizuki Kambara; Riruke Maruyama; Yasuhiko Akiyama
Journal:  Case Rep Med       Date:  2019-07-17

6.  Papillary craniopharyngioma in a patient following resection of nonfunctioning pituitary adenoma: illustrative case.

Authors:  David J Park; Akash Mishra; Danielle Golub; Jian Y Li; Karen S Black; Michael Schulder
Journal:  J Neurosurg Case Lessons       Date:  2021-01-11

7.  Collision tumors of the sella: coexistence of pituitary adenoma and craniopharyngioma in the sellar region.

Authors:  Guishan Jin; Shuyu Hao; Jian Xie; Ruifang Mi; Fusheng Liu
Journal:  World J Surg Oncol       Date:  2013-08-07       Impact factor: 2.754

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.